Insulin degludec/Insulin aspart（Yifan Pharma）
德谷胰岛素/门冬胰岛素（亿帆医药）
Report date: 2025/05/12 15:01:21
Base Information
Drug NameInsulin degludec/Insulin aspart（Yifan Pharma）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesYifan Pharmaceutical (Shanghai) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesYifan Pharmaceutical (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksKEGG